thebench.bio

Industry Daily Summary

Industry Daily Summary: What Happened on October 4, 2026

Brenntag gets global rights to dsm-firmenich’s biopharma vitamins

The companies will market eight GMP-grade vitamins for biopharmaceutical manufacturing under a new co-brand.

  • Updated
  • Read from 1 article, 1 publication
  • P

Today in brief

Brenntag Pharma won exclusive global distribution rights to dsm-firmenich’s Biond vitamin portfolio for biopharmaceutical manufacturing.1 The eight products will be sold as BYPHARM powered by Biond, extending a business relationship of more than 30 years.1